Human 17β-hydroxysteroid dehydrogenase type 5 is inhibited by dietary flavonoids

被引:0
|
作者
Krazeisen, A [1 ]
Breitling, R [1 ]
Möller, G [1 ]
Adamski, J [1 ]
机构
[1] GSF Natl Res Ctr Environm & Hlth, Inst Expt Genet, Genome Anal Ctr, D-85764 Neuherberg, Germany
来源
关键词
D O I
暂无
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Phytoestrogens contained in a vegetarian diet are supposed to have beneficial effects on the development and progression of a variety of endocrine-related cancers. We have tested the effect of a variety of dietary phytoestrogens, especially flavonoids, on the activity of human 17beta-hydroxysteroid dehydrogenase type 5 (17beta-HSD 5), a key enzyme in the metabolism of estrogens and androgens. Our studies show that reductive and oxidative activity of the enzyme are inhibited by many compounds, especially zearalenone, coumestrol, quercetin and biochanin A. Among flavones, inhibitor potency is enhanced with increased degree of hydroxylation. The most effective inhibitors seem to bind to the hydrophilic cofactor binding pocket of the enzyme.
引用
收藏
页码:151 / 161
页数:11
相关论文
共 50 条
  • [31] Purification, crystallization and preliminary X-ray diffraction results of human 17β-hydroxysteroid dehydrogenase type 5
    Zhou, M
    Qiu, W
    Chang, HJ
    Gangloff, A
    Lin, SX
    ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2002, 58 : 1048 - 1050
  • [32] Identification of a functional polymorphism of the human type 5 17β-hydroxysteroid dehydrogenase gene associated with polycystic ovary syndrome
    Qin, KN
    Ehrmann, DA
    Cox, N
    Refetoff, S
    Rosenfield, RL
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (01): : 270 - 276
  • [33] Multiple functions of type 10 17β-hydroxysteroid dehydrogenase
    Yang, SY
    He, XY
    Schulz, H
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2005, 16 (04): : 167 - 175
  • [34] New inhibitors of 17β-hydroxysteroid dehydrogenase type 1
    Messinger, J
    Hirvelä, L
    Husen, B
    Kangas, L
    Koskimies, P
    Pentikäinen, O
    Saarenketo, P
    Thole, H
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2006, 248 (1-2) : 192 - 198
  • [35] 17 beta-hydroxysteroid dehydrogenase activity correlates with the type-2 17 beta-hydroxysteroid dehydrogenase mRNA abundance in human meningioma tumors
    Carsol, JL
    Adamski, J
    Guirou, O
    Gerard, H
    Martin, PM
    deLaunoit, Y
    NEUROENDOCRINOLOGY, 1996, 64 (01) : 70 - 78
  • [36] Immunohistochemical localization of 17β-hydroxysteroid dehydrogenase, type 5, in normal and malignant endometrium.
    Talwalkar, SS
    Amezcua, C
    Qing, J
    Stolz, A
    Stanczyk, FZ
    Felix, J
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2004, 11 (02) : 139A - 139A
  • [37] Nonreplication of the type 5 17β-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome
    Goodarzi, Mark O.
    Jones, Michelle R.
    Antoine, Heath J.
    Pall, Marita
    Chen, Yii-Der I.
    Azziz, Ricardo
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (01): : 300 - 303
  • [38] The type 2 isozyme of 17β-hydroxysteroid dehydrogenase (17β-HSD) predominates in human sebaceous glands.
    Thiboutot, D
    Martin, P
    Volikas, L
    Gilliland, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 530 - 530
  • [39] 11β-Hydroxysteroid dehydrogenase-type 2 evolved from an ancestral 17β-Hydroxysteroid dehydrogenase-type 2
    Baker, Michael E.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 399 (02) : 215 - 220
  • [40] Androgen formation and metabolism in the pulmonary epithelial cell line A549:: Expression of 17β-hydroxysteroid dehydrogenase type 5 and 3α-hydroxysteroid dehydrogenase type 3
    Provost, PR
    Blomquist, CH
    Godin, C
    Huang, XF
    Flamand, N
    Luu-The, V
    Nadeau, D
    Tremblay, Y
    ENDOCRINOLOGY, 2000, 141 (08) : 2786 - 2794